## Related Work

**Related Papers**
1. **Title**: Multi-Armed Bandits and Clinical Medicine: A Survey
   - **Authors**: Xiwen Guo
   - **Summary**: Demonstrates that Thompson Sampling and contextual bandits provide robust exploration-exploitation balance in clinical settings, identifying integration with causal inference as a promising future direction.
   - **Year**: 2025

2. **Title**: From Prediction to Prescription: ML and Causal Inference for HTE
   - **Authors**: Judith Abécassis, Elise Dumas, J. Alberge, G. Varoquaux
   - **Summary**: Shows that machine learning can inform individualized interventions and that doubly-robust estimators enable valid causal inference for heterogeneous treatment effects.
   - **Year**: 2025

3. **Title**: Deep Reinforcement Learning for Personalized Treatment Planning
   - **Authors**: N. Vasavya et al.
   - **Summary**: Demonstrates that PPO-based deep reinforcement learning achieves 91.2% success rate in personalized treatment optimization.
   - **Year**: 2025

4. **Title**: Designing and evaluating advanced adaptive randomised clinical trials (arXiv:2501.08765)
   - **Authors**: Granholm et al.
   - **Summary**: Validates a Bayesian adaptive framework with response-adaptive randomization and provides practical guidance for adaptive trial design.
   - **Year**: 2025

5. **Title**: TrialGPT
   - **Authors**: Jin et al.
   - **Summary**: Provides a baseline approach for patient-trial matching based on eligibility criteria rather than treatment response prediction.
   - **Year**: 2024

6. **Title**: Standard Adaptive Designs
   - **Authors**: Not specified
   - **Summary**: Represents conventional adaptive trial designs using pre-specified rules and subgroups for treatment allocation rather than learned allocation strategies.
   - **Year**: Not specified

7. **Title**: Strategies for informed sample size reduction in adaptive clinical trials
   - **Authors**: Arandjelović
   - **Summary**: Demonstrates that sample size reduction is achievable through statistically informed adaptive methods in clinical trials.
   - **Year**: 2017

8. **Title**: Digital phenotyping of GAD using wearable sensors
   - **Authors**: Jacobson & Feng
   - **Summary**: Validates the digital biomarker approach by showing that wearable data can predict symptom severity with correlation r=0.511.
   - **Year**: 2022

**Key Challenges**
1. **Eligibility vs. Response Prediction Gap**: Existing approaches like TrialGPT focus on patient-trial matching based on eligibility criteria rather than predicting individual treatment response and heterogeneous treatment effects.

2. **Pre-specified vs. Learned Allocation**: Standard adaptive designs rely on pre-specified rules and subgroups for treatment allocation, lacking the flexibility of machine learning-predicted heterogeneous treatment effects for personalized allocation.

3. **Integration of Causal Inference with Adaptive Methods**: While multi-armed bandits and ML methods show promise individually, their integration with causal inference frameworks for clinical trials remains an underexplored future direction.

4. **Sample Size Efficiency**: Clinical trials require statistically informed adaptive methods to achieve meaningful sample size reductions while maintaining validity.

5. **Digital Biomarker Validation**: Leveraging digital phenotyping data from wearables for treatment effect prediction requires validation of the relationship between sensor data and clinical outcomes.
